Serum markers for type II diabetes mellitus
Abstract
A method for identifying persons with increased risk of developing type 2 diabetes mellitus utilizing selected biomarkers described hereafter either alone or in combination. The present invention allows for broad based, reliable, screening of large population bases and provides other advantages, including the formulation of effective strategies for characterizing, archiving, and contrasting data from multiple sample types under varying conditions.
- Inventors:
- Issue Date:
- Research Org.:
- Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1127136
- Patent Number(s):
- 8673644
- Application Number:
- 12/120,043
- Assignee:
- Battelle Memorial Institute (Richland, WA)
- Patent Classifications (CPCs):
-
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- DOE Contract Number:
- AC05-76RLO1830
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Metz, Thomas O, Qian, Wei-Jun, Jacobs, Jon M, Polpitiya, Ashoka D, Camp, II, David G, and Smith, Richard D. Serum markers for type II diabetes mellitus. United States: N. p., 2014.
Web.
Metz, Thomas O, Qian, Wei-Jun, Jacobs, Jon M, Polpitiya, Ashoka D, Camp, II, David G, & Smith, Richard D. Serum markers for type II diabetes mellitus. United States.
Metz, Thomas O, Qian, Wei-Jun, Jacobs, Jon M, Polpitiya, Ashoka D, Camp, II, David G, and Smith, Richard D. Tue .
"Serum markers for type II diabetes mellitus". United States. https://www.osti.gov/servlets/purl/1127136.
@article{osti_1127136,
title = {Serum markers for type II diabetes mellitus},
author = {Metz, Thomas O and Qian, Wei-Jun and Jacobs, Jon M and Polpitiya, Ashoka D and Camp, II, David G and Smith, Richard D},
abstractNote = {A method for identifying persons with increased risk of developing type 2 diabetes mellitus utilizing selected biomarkers described hereafter either alone or in combination. The present invention allows for broad based, reliable, screening of large population bases and provides other advantages, including the formulation of effective strategies for characterizing, archiving, and contrasting data from multiple sample types under varying conditions.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2014},
month = {3}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
patent-application, June 2006
- Jackowski, George; Marshall, John
- US Patent Application 11/351461; 20060134699
Complement C3 Precursor Biopolymer Markers Predictive of Type II Diabetes
patent-application, July 2006
- Jackowski, George; Marshall, John
- US Patent Application 09/993287; 20060160232
Markers associated with arteriovascular events and methods of use thereof
patent-application, March 2008
- Urdea, Mickey; McKenna, Michael; Arensdorf, Patrick
- US Patent Application 11/811441; 20080057590
Assay for Diabetes
patent-application, August 2008
- Walsh, Bradley John; Randall, Geoffrey Bruce; Wilson, Steven Brian
- US Patent Application 12/035290; 20080188004
Application of Proteomics in the Discovery of Candidate Protein Biomarkers in a Diabetes Autoantibody Standardization Program Sample Subset
journal, February 2008
- Metz, Thomas O.; Qian, Wei-Jun; Jacobs, Jon M.
- Journal of Proteome Research, Vol. 7, Issue 2